Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Jun 20, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Kymera Therapeutics, Inc.
0
—
—
—
0
Jun 18
Beam Therapeutics Inc.
0
—
—
—
0
Jun 5
Rapport Therapeutics, Inc.
0
—
—
—
0
Prokidney Corp.
0
—
—
—
0
Jun 29
Kymera Therapeutics, Inc.
0
—
—
—
0
Jun 15
Beam Therapeutics Inc.
0
—
—
—
0
Jun 6
Beam Therapeutics Inc.
0
—
—
—
0
Sep 1
Prokidney Corp.
0
—
—
—
0
Jul 11
Prokidney Corp.
0
—
—
—
0
Agios Pharmaceuticals, Inc.
0
—
—
—
0
Jun 21
Agios Pharmaceuticals, Inc.
1.58K
—
—
+5.57%
30.03K
May 20
Kymera Therapeutics, Inc.
0
—
—
—
0
Jan 18
Kymera Therapeutics, Inc.
0
—
—
—
0
Alnylam Pharmaceuticals, Inc.
7.53K
$188.98
-$1,254,077.33
+3.42%
227.66K
Dec 21 - Dec 22
Alnylam Pharmaceuticals, Inc.
5.37K
$74.50
$399,829.03
+2.50%
220.13K
Dec 10
Alnylam Pharmaceuticals, Inc.
0
$89.31
-$5,586,556.81
—
214.76K
Nov 12
Scheduled
Beam Therapeutics Inc.
0
—
—
—
0
Nov 5
Beam Therapeutics Inc.
0
—
—
—
0
Alnylam Pharmaceuticals, Inc.
0
$103.44
-$6,546,945.06
—
214.76K
Aug 13
Scheduled
Agios Pharmaceuticals, Inc.
-1.73K
—
—
-5.73%
28.44K
Feb 4 - May 28
Agios Pharmaceuticals, Inc.
0
—
—
—
0
May 20
Alnylam Pharmaceuticals, Inc.
0
$68.94
-$4,202,473.99
—
214.76K
May 13
Scheduled
Alnylam Pharmaceuticals, Inc.
8.73K
$131.85
-$989,822.04
+4.24%
214.76K
Apr 19 - Apr 20
Alnylam Pharmaceuticals, Inc.
0
$77.21
-$4,764,170.36
—
206.04K
Feb 24 - Feb 25
Scheduled
Alnylam Pharmaceuticals, Inc.
8.45K
$155.78
-$890,916.66
+4.28%
206.04K
Feb 11 - Feb 12
Alnylam Pharmaceuticals, Inc.
0
$66.69
-$4,001,273.05
—
197.59K
Nov 19
Scheduled
Alnylam Pharmaceuticals, Inc.
0
$72.63
-$4,414,790.13
—
197.59K
Aug 20
Scheduled
Agios Pharmaceuticals, Inc.
1.88K
—
—
+6.64%
30.17K
May 28 - May 29
Alnylam Pharmaceuticals, Inc.
0
$76.18
-$4,661,230.96
—
197.59K
May 20
Scheduled
Alnylam Pharmaceuticals, Inc.
7.6K
$104.81
-$688,701.37
+4.00%
197.59K
Apr 7
Agios Pharmaceuticals, Inc.
-4.32K
—
—
-13.23%
28.29K
Feb 14
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
Feb 26
Alnylam Pharmaceuticals, Inc.
0
$70.50
-$4,265,922.19
—
189.99K
Feb 20
Scheduled
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
Dec 23
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
Nov 22
Alnylam Pharmaceuticals, Inc.
0
$47.94
-$3,116,648.26
—
189.99K
Oct 14
Scheduled
Alnylam Pharmaceuticals, Inc.
34
—
—
+1.10%
3.13K
Jul 11 - Aug 6
Agios Pharmaceuticals Inc
-5.00K
—
—
-13.29%
32.61K
Jun 12
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
Jun 5
Agios Pharmaceuticals Inc
1.4K
—
—
+3.87%
37.61K
May 29 - May 31

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.